ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 761

$556K Total Retail Price of All Prescriptions

Rank: 91 out of 761

540 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
30% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 540 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

10% of this provider’s 540 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 11,629 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $54 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
LISINOPRIL 560 519 1 1
FUROSEMIDE 505 465 2 7
OMEPRAZOLE 505 468 2 4
LEVOTHYROXINE SODIUM 454 400 4 3
LOVASTATIN 418 375 5 17
ATENOLOL 330 309 6 8
AMLODIPINE BESYLATE 310 292 7 6
POTASSIUM CHLORIDE 274 241 8 18
METFORMIN HCL ER 259 235 9 67
MIRTAZAPINE 252 245 10 50
HYDROCODONE-ACETAMINOPHEN 245 232 S3 11 5
SPIRONOLACTONE 237 224 12 45
LOSARTAN POTASSIUM 231 212 13 13
GABAPENTIN 218 195 14 15
DONEPEZIL HCL 183 183 15 33
PRAVASTATIN SODIUM 173 156 16 20
RANITIDINE HCL 166 154 17 52
FLUOXETINE HCL 165 142 18 31
MELOXICAM 165 160 18 61
CRESTOR 160 138 20 36
HYDROCHLOROTHIAZIDE 159 143 21 11
GLIMEPIRIDE 158 143 22 48
ATORVASTATIN CALCIUM 154 147 23 12
SIMVASTATIN 140 126 24 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 139 129 25 35
CARBIDOPA-LEVODOPA 138 130 26 82
ALLOPURINOL 134 130 27 28
CITALOPRAM HBR 132 111 28 19
TRAMADOL HCL 130 123 29 34
INDAPAMIDE 129 118 30 168
FLUTICASONE PROPIONATE 126 111 31 29
FINASTERIDE 108 94 32 73
ZOLPIDEM TARTRATE 107 104 33 22
TAMSULOSIN HCL 106 102 34 27
PREDNISONE 103 102 35 30
METFORMIN HCL 102 89 36 10
METOPROLOL SUCCINATE 100 100 37 16
ALENDRONATE SODIUM 96 89 38 21
DIGOXIN 87 87 39 43
METOPROLOL TARTRATE 86 86 40 14
WARFARIN SODIUM 73 73 41 9
TRAZODONE HCL 71 61 42 23
PULMICORT FLEXHALER 71 61 42 294
LOSARTAN-HYDROCHLOROTHIAZIDE 70 70 44 65
NORTRIPTYLINE HCL 70 65 44 101
CARVEDILOL 66 54 46 26
FELODIPINE ER 66 63 46 108
PANTOPRAZOLE SODIUM 66 54 46 40
ISOSORBIDE MONONITRATE ER 64 57 49 72
NAMENDA 62 62 50 59
SERTRALINE HCL 62 54 50 25
DOXAZOSIN MESYLATE 59 59 52 55
VENLAFAXINE HCL ER 55 45 53 76
AGGRENOX 54 54 54 121
COMBIVENT 52 52 55 110
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.